DK0629199T3 - Indolderivater som 5-HT1 agonister - Google Patents

Indolderivater som 5-HT1 agonister

Info

Publication number
DK0629199T3
DK0629199T3 DK93906214T DK93906214T DK0629199T3 DK 0629199 T3 DK0629199 T3 DK 0629199T3 DK 93906214 T DK93906214 T DK 93906214T DK 93906214 T DK93906214 T DK 93906214T DK 0629199 T3 DK0629199 T3 DK 0629199T3
Authority
DK
Denmark
Prior art keywords
pct
compounds
agonists
sec
nitrogen
Prior art date
Application number
DK93906214T
Other languages
Danish (da)
English (en)
Inventor
John E Macor
Jolanta T Nowakowski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of DK0629199T3 publication Critical patent/DK0629199T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93906214T 1992-03-05 1993-03-03 Indolderivater som 5-HT1 agonister DK0629199T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84664092A 1992-03-05 1992-03-05
PCT/US1993/001667 WO1993018032A1 (en) 1992-03-05 1993-03-03 Indole derivatives as 5-ht1 agonists

Publications (1)

Publication Number Publication Date
DK0629199T3 true DK0629199T3 (da) 2002-07-15

Family

ID=25298499

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93906214T DK0629199T3 (da) 1992-03-05 1993-03-03 Indolderivater som 5-HT1 agonister

Country Status (30)

Country Link
US (2) US5594014A (ru)
EP (1) EP0629199B1 (ru)
JP (1) JPH07121943B2 (ru)
KR (1) KR0179073B1 (ru)
CN (4) CN1032309C (ru)
AT (1) ATE218566T1 (ru)
AU (1) AU666716B2 (ru)
BR (1) BR9306012A (ru)
CA (1) CA2117643C (ru)
CZ (1) CZ282652B6 (ru)
DE (1) DE69331988T2 (ru)
DK (1) DK0629199T3 (ru)
EG (1) EG20416A (ru)
ES (1) ES2176199T3 (ru)
FI (1) FI930968A (ru)
HU (1) HU219489B (ru)
IL (1) IL104941A (ru)
MX (1) MX9301197A (ru)
MY (1) MY109298A (ru)
NO (1) NO302617B1 (ru)
NZ (1) NZ249755A (ru)
PL (1) PL172388B1 (ru)
PT (1) PT629199E (ru)
RU (1) RU2124012C1 (ru)
SK (1) SK281938B6 (ru)
TW (1) TW288010B (ru)
UA (1) UA39866C2 (ru)
WO (1) WO1993018032A1 (ru)
YU (1) YU14893A (ru)
ZA (1) ZA931539B (ru)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607951A (en) * 1990-10-15 1997-03-04 Pfizer Inc Indole derivatives
US5559246A (en) * 1990-10-15 1996-09-24 Pfizer Inc. Indole derivatives
US5578612A (en) * 1990-10-15 1996-11-26 Pfizer Inc. Indole derivatives
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
US5559129A (en) * 1990-10-15 1996-09-24 Pfizer Inc Indole derivatives
AU670579B2 (en) 1992-04-07 1996-07-25 Pfizer Inc. Indole derivatives as 5-HT1 agonists
US6380233B1 (en) 1992-04-07 2002-04-30 Pfizer Inc Indole derivatives as 5-HT1 agonists
DE69413240T2 (de) * 1993-08-31 1999-02-04 Pfizer 5-arylindolderivate
GB9417310D0 (en) 1994-08-27 1994-10-19 Pfizer Ltd Therapeutic agents
GB9420503D0 (en) * 1994-10-11 1994-11-23 Pfizer Ltd Therapeutic agents
GB9420529D0 (en) 1994-10-12 1994-11-30 Pfizer Ltd Indoles
WO1997024343A1 (en) 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Phenyl thiazole derivatives with anti herpes virus properties
US6288091B1 (en) 1995-12-29 2001-09-11 Boehringer Ingelheim Ltd. Antiherpes virus compounds and methods for their preparation and use
US5994352A (en) * 1998-11-13 1999-11-30 Pfizer Inc. 5-arylindole derivatives
MXPA03004623A (es) 2000-11-27 2003-09-05 Pfizer Prod Inc Agonistas selectivos del receptor ep4 en el tratamiento de la osteoporosis.
CN1293073C (zh) * 2001-04-20 2007-01-03 惠氏公司 作为5－羟色胺－6配体的杂环基烷氧基－、－烷硫基－和－烷基氨基吲哚衍生物
ITRM20020255A1 (it) * 2002-05-09 2003-11-10 Polifarma Spa Tautomero enolico dell'acido 3-indolilpiruvico, suoi sali e usi terapeutici.
ES2199086B1 (es) * 2002-07-31 2005-06-01 Cepa Schwarz Pharma Sl Nuevos derivados de cicloalcanodionas, procedimiento para su preparacion y sus aplicaciones farmacologicas.
CA2891122C (en) 2012-11-14 2021-07-20 The Johns Hopkins University Methods and compositions for treating schizophrenia
KR20220137085A (ko) * 2020-02-04 2022-10-11 마인드셋 파마 인크. Cns 장애의 치료를 위한 세로토닌성 사이키델릭 작용제로서의 3-피롤리딘-인돌 유도체

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA795239B (en) * 1978-10-12 1980-11-26 Glaxo Group Ltd Heterocyclic compounds
ZA815541B (en) * 1980-08-12 1983-03-30 Glaxo Group Ltd Heterocyclic compounds
GB8600397D0 (en) * 1986-01-08 1986-02-12 Glaxo Group Ltd Chemical compounds
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
GB8724912D0 (en) * 1987-10-23 1987-11-25 Wellcome Found Indole derivatives
GB8819024D0 (en) * 1988-08-10 1988-09-14 Glaxo Group Ltd Chemical compounds
IL96891A0 (en) * 1990-01-17 1992-03-29 Merck Sharp & Dohme Indole-substituted five-membered heteroaromatic compounds,their preparation and pharmaceutical compositions containing them
CA2042295A1 (fr) * 1990-05-15 1991-11-16 Jacques Chauveau Derives de mediateurs endogenes, leurs sels, procede de preparation, applications, et compositions les renfermant
HU219974B (hu) * 1990-06-07 2001-10-28 Astrazeneca Ab, Heterociklusos csoporttal helyettesített indolszármazék, előállítása és a vegyületet hatóanyagként tartalmazó gyógyszerkészítmények
HUT64326A (en) * 1990-10-15 1993-12-28 Pfizer Process for production indole derivatives and pharmaceutical preparations containing these compounds
US5208248A (en) * 1991-01-11 1993-05-04 Merck Sharpe & Dohme, Ltd. Indazole-substituted five-membered heteroaromatic compounds
SK278998B6 (sk) * 1991-02-01 1998-05-06 Merck Sharp & Dohme Limited Deriváty imidazolu, triazolu a tetrazolu, spôsob i
TW263508B (ru) * 1991-02-12 1995-11-21 Pfizer

Also Published As

Publication number Publication date
SK281938B6 (sk) 2001-09-11
FI930968A0 (fi) 1993-03-04
CN1082044A (zh) 1994-02-16
SK105294A3 (en) 1995-05-10
CZ212594A3 (en) 1995-06-14
AU666716B2 (en) 1996-02-22
YU14893A (sh) 1996-05-20
NZ249755A (en) 1996-08-27
CN1136566A (zh) 1996-11-27
CA2117643A1 (en) 1993-09-16
HU9300593D0 (en) 1993-05-28
KR950700291A (ko) 1995-01-16
IL104941A0 (en) 1993-07-08
FI930968A (fi) 1993-09-06
RU94040914A (ru) 1996-08-10
MY109298A (en) 1996-12-31
NO302617B1 (no) 1998-03-30
US5594014A (en) 1997-01-14
RU2124012C1 (ru) 1998-12-27
DE69331988D1 (de) 2002-07-11
WO1993018032A1 (en) 1993-09-16
CN1082815C (zh) 2002-04-17
CN1136565A (zh) 1996-11-27
CA2117643C (en) 2000-03-14
UA39866C2 (uk) 2001-07-16
CN1044909C (zh) 1999-09-01
ZA931539B (en) 1994-09-05
HU219489B (hu) 2001-04-28
CZ282652B6 (cs) 1997-08-13
IL104941A (en) 1998-06-15
CN1044910C (zh) 1999-09-01
US5717102A (en) 1998-02-10
NO943261L (no) 1994-09-02
EP0629199B1 (en) 2002-06-05
CN1032309C (zh) 1996-07-17
JPH07121943B2 (ja) 1995-12-25
ATE218566T1 (de) 2002-06-15
TW288010B (ru) 1996-10-11
NO943261D0 (no) 1994-09-02
AU3733093A (en) 1993-10-05
DE69331988T2 (de) 2002-09-19
KR0179073B1 (ko) 1999-03-20
PL172388B1 (pl) 1997-09-30
ES2176199T3 (es) 2002-12-01
BR9306012A (pt) 1997-11-18
HUT64061A (en) 1993-11-29
EP0629199A1 (en) 1994-12-21
CN1136432A (zh) 1996-11-27
EG20416A (en) 1999-02-28
PT629199E (pt) 2002-09-30
JPH07500353A (ja) 1995-01-12
MX9301197A (es) 1993-09-01

Similar Documents

Publication Publication Date Title
EG21209A (en) Indole derivatives
DK0629199T3 (da) Indolderivater som 5-HT1 agonister
MX9700693A (es) Derivados del 4-indol.
DK0635015T3 (da) Acylaminoindolderivater som 5-Htl agonister
ES2070772A1 (es) Derivados de acilaminoindol